Applied DNA Sciences, Inc. (BNBX) — Financial Flexibility Index
Applied DNA Sciences, Inc. (BNBX) has a Financial Flexibility Index of -1.36x as of March 2026. Free cash flow of $-2.05 Million (operating CF $-2.05 Million minus capex $3.00) represents -1% of total liabilities ($1.50 Million). Check Applied DNA Sciences, Inc. strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Applied DNA Sciences, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Applied DNA Sciences, Inc. across 5 annual periods. See Applied DNA Sciences, Inc. (BNBX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Applied DNA Sciences, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Applied DNA Sciences, Inc.. For the full company profile including market capitalisation, see Applied DNA Sciences, Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.89x | $-12.21 Million | $-12.52 Million | $2.50 Million | ▼ -40.5% |
| 2024 | -3.48x | $-13.30 Million | $-13.71 Million | $3.82 Million | ▼ -397.9% |
| 2023 | -0.70x | $-6.14 Million | $-6.22 Million | $8.78 Million | ▲ +22.9% |
| 2022 | -0.91x | $-8.49 Million | $-8.98 Million | $9.36 Million | ▲ +72.4% |
| 2021 | -3.28x | $-10.84 Million | $-13.39 Million | $3.30 Million | — |